Drugs / OPL-0301
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05327855 | Sep 2022 → Aug 2024 | myocardial infarction | Valo Health, Inc. | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OPL-0301 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05327855 ↗ |
| Route | Oral | “Route of administration: Oral” NCT05327855 ↗ |